ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,767.50
0.10%
S&P ASX All Technology
3,137.90
0.55%
Brent Oil
84.85
0.00%
US Dollar vs AUD
1.49566
0.00%
Bitcoin
60,904.08
0.98%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. ETFs
  4. USA
  5. AMEX
  6. Emles at Home ETF (LIV)

  7. Emles at Home ETF (LIV) News

LIV

Emles at Home ETF (LIV)

Emles at Home ETF
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:LIV
DateTimeSourceHeadlineSymbolCompany
17/09/202207:00PR Newswire (US)Emles Advisors Announces Closure of Six FundsAMEX:LIVEmles at Home ETF
14/12/200702:15Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filing (8-K)AMEX:LIVEmles at Home ETF
28/11/200701:17Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filing (8-K)AMEX:LIVEmles at Home ETF
20/11/200704:52Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Quarterly Report (10-Q)AMEX:LIVEmles at Home ETF
16/11/200706:16Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Notification that Quarterly Report will be submitted late (NT 10-Q)AMEX:LIVEmles at Home ETF
13/11/200722:06Edgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other)AMEX:LIVEmles at Home ETF
09/11/200702:06Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filingAMEX:LIVEmles at Home ETF
03/10/200723:54Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filing (8-K)AMEX:LIVEmles at Home ETF
03/10/200723:54Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filing (8-K)AMEX:LIVEmles at Home ETF
02/10/200700:00Edgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other) (8-K)AMEX:LIVEmles at Home ETF
29/09/200700:00Edgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other) (8-K)AMEX:LIVEmles at Home ETF
22/09/200706:43Edgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other) (8-K)AMEX:LIVEmles at Home ETF
21/09/200700:00Edgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other) (8-K)AMEX:LIVEmles at Home ETF
18/09/200723:10Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filing (8-K)AMEX:LIVEmles at Home ETF
16/06/200600:09Business WireSamaritan to Initiate Phase III Clinical Trial in Europe to Accelerate Development Timeline of Its HIV Oral Entry Inhibitor SP0AMEX:LIVEmles at Home ETF
30/05/200622:59Business WireSamaritan Reports Positive Preliminary Results with ''Oral'' HIV Entry Inhibitor in Phase II 10-Day HIV Monotherapy TrialAMEX:LIVEmles at Home ETF
23/05/200623:22Business WireSamaritan Files Provisional Patent to Support Promising New Type of Anti-cholesterol Drug SP-1000 and Cover Additional Claims;AMEX:LIVEmles at Home ETF
02/05/200623:15Business WireSamaritan Starts Enrolling for Its PII Stage 2 (28 Day Monotherapy) Study of ''Oral'' Entry Inhibitor SP-01AAMEX:LIVEmles at Home ETF
25/04/200622:00Business WireSIS Foundation Driven to Drive Bio Future Bus So Kids Can Speed up Science Innovation; Only 17% of US Students Graduate with ScAMEX:LIVEmles at Home ETF
14/04/200603:13Business WireBio 2006 Analysts Predict Small-Cap Biotechs to Outperform Large-Caps This YearAMEX:LIVEmles at Home ETF
06/04/200622:30Business WireLIV to Host Annual Shareholders MeetingAMEX:LIVEmles at Home ETF
04/04/200623:15Business WireSamaritan's Marketing Authorization Application For Amphocil Approved in GreeceAMEX:LIVEmles at Home ETF
31/03/200601:15Business WireSamaritan to Present Its Drugs and Diagnostics for Partnering at BIO 2006 Annual International ConferenceAMEX:LIVEmles at Home ETF
29/03/200601:27Business WireNew Preclinical Data Shows Samaritan's Cardiovascular Drug Reduces Cholesterol; Cardiovascular Disease is a $15B Market WorldwiAMEX:LIVEmles at Home ETF
24/03/200601:30Business WireSamaritan is the Little Biotech That Could Be Remembered for Alzheimer'sAMEX:LIVEmles at Home ETF
22/03/200615:01Business WireCORRECTING and REPLACING Samaritan's Adult Stem Cell Drug Displays Money-Making SignsAMEX:LIVEmles at Home ETF
22/03/200602:29Business WireSamaritan's Adult Stem Cell Drug Displays Money-Making SignsAMEX:LIVEmles at Home ETF
10/03/200600:00Business WireUPDATE: Samaritan Kicks Off Follow-On HIV StudyAMEX:LIVEmles at Home ETF
02/03/200600:00Business WireDistinguished Cancer Drug Developer Joins Samaritan Scientific Advisory BoardAMEX:LIVEmles at Home ETF
01/03/200600:00Business WireSamaritan's Alzheimer's Drug Registered as CAPROSPINOL; SP-233 (Caprospinol) is Believed to Exhibit Neuroprotective PropertiesAMEX:LIVEmles at Home ETF
 Showing the most relevant articles for your search:AMEX:LIV

Your Recent History

FX
EURAUD
Euro vs AUD
ASX
XTO
S&P ASX 100
COIN
BTCUSD
Bitcoin
ASX
XFL
S&P ASX 50
ASX
BHP
BHP
ASX
ORG
Origin Energy
FX
AUDUSD
AUD vs US Dollar
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
TSLA
Tesla
ASX
WES
Wesfarmers
ASX
AMP
AMP
ASX
RIO
Rio Tinto
NASDAQ
NVDA
NVIDIA
ASX
NAB
National Australia Bank
ASX
ANZ
Australia And New Zealan...
ASX
XJO
S&P ASX 200
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved